THMO Description — ThermoGenesis Holdings Inc
ThermoGenesis Holdings is engaged in the development and commercialization of automated cell processing technologies for the cell and gene therapy field. Co. markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform. Co. provides the AutoXpress® and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform under development for bio-manufacturing for immuno-oncology applications. Co. has two business segments: Device Segment and Clinical Development Segment.